Oncotalks | Powered by Novartis

EHA 2019 Alberto Ferrari, PhD

EHA , Lithuania , Albania
Share this item

Alberto Ferrari, PhD commenting on his abstract RATE OF THROMBOSIS IN CONTEMPORARY PATIENTS WITH POLYCYTHEMIA VERA UNDER HYDROXYUREA REMAINS EXCEEDINGLY HIGH, which he presented at EHA 2019 in Amsterdam

Reference: EHA Library. Ferrari A. Jun 14, 2019; 266470

Link to article: https://library.ehaweb.org/eha/2019/24th/266470/alberto.ferrari.rate.of.thrombosis.in.contemporary.patients.with.polycythemia.html

Related items

EHA 2019 Jeroen Janssen, MD, PhD

EHA 2019 Jeroen Janssen, MD, PhD

Jeroen Janssen MD, PhD from the Amsterdam UMC, Amsterdam, The Netherlands is commenting on the abstract COMBINATION THERAPY USING ASCIMINIB PLUS IMATINIB (IMA) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML) & COMBINATION OF ASCIMINIB PLUS NILOTINIB (NIL) OR DASATINIB (DAS) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA Reference: EHA Library. Kew S. Jun 15, 2019; 267467Link to abstract: https://library.ehaweb.org/eha/2019/24th/267467/sam.kew.combination.of.asciminib.plus.nilotinib.28nil29.or.dasatinib.28das29.in.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dasciminib

EHA , Latvia , Lithuania , Estonia , Albania

00:05:04

EHA 2019 Francesco Zaja, MD, PhD

EHA 2019 Francesco Zaja, MD, PhD

Zaja Francesco, MD, PhD from the Azienda Sanitaria Universitaria Integrata di, Trieste, Italy is commenting on the ITP highlights of EHA 2019 in Amsterdam

EHA , Lithuania , Albania

00:03:51

EHA 2019 Chinmay Munje, MD, PhD

EHA 2019 Chinmay Munje, MD, PhD

Chinmay Munje, MD, PhD from the Paul O’Gorman Leukaemia Research Centre, Glasgow, UK is commenting on the publication "COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS", which was presented at EHA 2019 in AmsterdamReference: EHA Library. BARRACO F. Jun 14, 2019; 266478https://library.ehaweb.org/eha/2019/24th/266478/fiorenza.barraco.real-world.safety.data.from.a.noninterventional.long-term.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DREAL-WORLD+SAFETY+DATA+FROM+A+NONINTERVENTIONAL+LONG-TERM+POSTAUTHORIZATION+SAFETY+STUDY+OF+RUXOLITINIB+IN+MYELOFIBROSIS

EHA , Lithuania , Albania

00:04:34

EHA 2019 Gregor Horman, MD, PhD

EHA 2019 Gregor Horman, MD, PhD

Gregor Horman, MD, PhD from the Medical University of Vienna is talking about data on next generation sequencing presented at the 24th EHA meeting held in Amsterdam

EHA , Lithuania , Albania

00:05:10

EHA 2019 Wolfgang Willenbacher, MD, PhD

EHA 2019 Wolfgang Willenbacher, MD, PhD

Wolfgang Willenbacher, MD, PhD from the Wolfgang Willenbacher, MD, PhD is commenting on the abstract PATIENT PERCEPTIONS ON SPLENECTOMY OUTCOMES: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH), which was presented at EHA 2019 in AmsterdamReference: EHA Library. Cooper N. Jun 14, 2019; 266513Link to abstract: https://library.ehaweb.org/eha/2019/24th/266513/nichola.cooper.patient.perceptions.on.splenectomy.outcomes.results.from.the.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DPATIENT+PERCEPTIONS+ON+SPLENECTOMY+OUTCOMES%3A+RESULTS+FROM+THE+ITP+WORLD+IMPACT+SURVEY+%28I-WISH%29

EHA , Lithuania , Albania

00:04:30

EHA 2019 Natalia Curto-Garcia, MD, PhD

EHA 2019 Natalia Curto-Garcia, MD, PhD

Natalia Curto-Garcia, MD, PhD from the Guys and St Thomas NHS Foundation Trust, London, United Kingdom is commenting on MOLECULAR ANALYSIS IN MAJIC PV CORRELATION WITH CLINICAL ENDPOINTS, which she presented at EHA 2019 in AmsterdamReference: EHA Library. Curto-Garcia N. Jun 16, 2019; 26736Link to abstract: https://library.ehaweb.org/eha/2019/24th/267361/natalia.curto-garcia.molecular.analysis.in.majic.pv.correlation.with.clinical.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dmolecular+analysis%2Bmajic+pv+correlation%2Bclinical+endpoints

EHA , Lithuania , Albania

00:02:21